Search

Bharati R Dhruva

Examiner (ID: 3913)

Most Active Art Unit
1632
Art Unit(s)
1632
Total Applications
2
Issued Applications
1
Pending Applications
1
Abandoned Applications
0

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8146299 [patent_doc_number] => 08163305 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Targeted cross-linked nanoparticles and their use in vivo gene delivery' [patent_app_type] => utility [patent_app_number] => 12/195261 [patent_app_country] => US [patent_app_date] => 2008-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 10486 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163305.pdf [firstpage_image] =>[orig_patent_app_number] => 12195261 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/195261
Targeted cross-linked nanoparticles and their use in vivo gene delivery Aug 19, 2008 Issued
Array ( [id] => 5416942 [patent_doc_number] => 20090042829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Nucleic Acid-Lipopolymer Compositions' [patent_app_type] => utility [patent_app_number] => 12/186945 [patent_app_country] => US [patent_app_date] => 2008-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11469 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042829.pdf [firstpage_image] =>[orig_patent_app_number] => 12186945 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/186945
Nucleic Acid-Lipopolymer Compositions Aug 5, 2008 Abandoned
Array ( [id] => 6520148 [patent_doc_number] => 20100203115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'ORGANIC-INORGANIC HYBRID MATERIAL FOR THE STORAGE AND RELEASE OF ACTIVE PRINCIPLES' [patent_app_type] => utility [patent_app_number] => 12/671235 [patent_app_country] => US [patent_app_date] => 2008-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5565 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203115.pdf [firstpage_image] =>[orig_patent_app_number] => 12671235 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/671235
ORGANIC-INORGANIC HYBRID MATERIAL FOR THE STORAGE AND RELEASE OF ACTIVE PRINCIPLES Jul 29, 2008 Abandoned
Array ( [id] => 8982092 [patent_doc_number] => 08513206 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-20 [patent_title] => 'Crosslinked PEI nanoparticle transfection agents for delivery of biomolecules with increased efficiency' [patent_app_type] => utility [patent_app_number] => 12/181798 [patent_app_country] => US [patent_app_date] => 2008-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 22 [patent_no_of_words] => 6965 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12181798 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/181798
Crosslinked PEI nanoparticle transfection agents for delivery of biomolecules with increased efficiency Jul 28, 2008 Issued
Array ( [id] => 8264649 [patent_doc_number] => 20120164073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'Stable nanoparticles, nanoparticle-based imaging systems, nanoparticle-based assays, and in vivo assays for screening biocompatibility and toxicity of nanoparticles' [patent_app_type] => utility [patent_app_number] => 12/219223 [patent_app_country] => US [patent_app_date] => 2008-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 13136 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12219223 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/219223
Stable nanoparticles, nanoparticle-based imaging systems, nanoparticle-based assays, and in vivo assays for screening biocompatibility and toxicity of nanoparticles Jul 16, 2008 Abandoned
Array ( [id] => 5296096 [patent_doc_number] => 20090011022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Use of deuterium oxide for treatment of virus-based diseases of the skin' [patent_app_type] => utility [patent_app_number] => 12/168583 [patent_app_country] => US [patent_app_date] => 2008-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15272 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0011/20090011022.pdf [firstpage_image] =>[orig_patent_app_number] => 12168583 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/168583
Use of deuterium oxide for treatment of herpes virus-based diseases of the skin Jul 6, 2008 Issued
Array ( [id] => 6563331 [patent_doc_number] => 20100272812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'RGD-MODIFIED ALGINATE MICROPARTICLES AS A DRUG RELEASE SYSTEM' [patent_app_type] => utility [patent_app_number] => 12/666677 [patent_app_country] => US [patent_app_date] => 2008-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7149 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20100272812.pdf [firstpage_image] =>[orig_patent_app_number] => 12666677 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/666677
RGD-MODIFIED ALGINATE MICROPARTICLES AS A DRUG RELEASE SYSTEM Jun 24, 2008 Abandoned
Array ( [id] => 4949890 [patent_doc_number] => 20080306016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Nucleic Acid Functionalized Nanoparticles for Therapeutic Applications' [patent_app_type] => utility [patent_app_number] => 12/130643 [patent_app_country] => US [patent_app_date] => 2008-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19869 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20080306016.pdf [firstpage_image] =>[orig_patent_app_number] => 12130643 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/130643
Nucleic acid functionalized nanoparticles for therapeutic applications May 29, 2008 Issued
Array ( [id] => 5348785 [patent_doc_number] => 20090004146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'Humanised Baculovirus' [patent_app_type] => utility [patent_app_number] => 12/123821 [patent_app_country] => US [patent_app_date] => 2008-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5082 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20090004146.pdf [firstpage_image] =>[orig_patent_app_number] => 12123821 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/123821
Humanised Baculovirus May 19, 2008 Abandoned
Array ( [id] => 4663202 [patent_doc_number] => 20080254109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'LOCALIZED MYOCARDIAL INJECTION METHOD FOR TREATING ISCHEMIC MYOCARDIUM' [patent_app_type] => utility [patent_app_number] => 12/122561 [patent_app_country] => US [patent_app_date] => 2008-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5570 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20080254109.pdf [firstpage_image] =>[orig_patent_app_number] => 12122561 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/122561
LOCALIZED MYOCARDIAL INJECTION METHOD FOR TREATING ISCHEMIC MYOCARDIUM May 15, 2008 Abandoned
Array ( [id] => 4675680 [patent_doc_number] => 20080213309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'MULTI-ANTIGENIC ALPHAVIRUS REPLICON PARTICLES AND METHODS' [patent_app_type] => utility [patent_app_number] => 12/116031 [patent_app_country] => US [patent_app_date] => 2008-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17524 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213309.pdf [firstpage_image] =>[orig_patent_app_number] => 12116031 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/116031
Multi-antigenic alphavirus replicon particles and methods May 5, 2008 Issued
Array ( [id] => 8981584 [patent_doc_number] => 08512697 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-20 [patent_title] => 'Delivery of micro- and nanoparticles with blood platelets' [patent_app_type] => utility [patent_app_number] => 12/150562 [patent_app_country] => US [patent_app_date] => 2008-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 10670 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12150562 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/150562
Delivery of micro- and nanoparticles with blood platelets Apr 28, 2008 Issued
Array ( [id] => 5928877 [patent_doc_number] => 20110038836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'Device and Method for Transfecting Cells for Therapeutic Use' [patent_app_type] => utility [patent_app_number] => 12/674151 [patent_app_country] => US [patent_app_date] => 2008-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 13663 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20110038836.pdf [firstpage_image] =>[orig_patent_app_number] => 12674151 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/674151
Device and Method for Transfecting Cells for Therapeutic Use Apr 22, 2008 Abandoned
Array ( [id] => 5385280 [patent_doc_number] => 20090226525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'Self-assembling nanoparticle drug delivery system' [patent_app_type] => utility [patent_app_number] => 12/082154 [patent_app_country] => US [patent_app_date] => 2008-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 22684 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20090226525.pdf [firstpage_image] =>[orig_patent_app_number] => 12082154 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/082154
Self-assembling nanoparticle drug delivery system Apr 8, 2008 Abandoned
Array ( [id] => 8543564 [patent_doc_number] => 08318856 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-27 [patent_title] => 'Nucleic acid delivery system comprising conjugates of PEI and hyaluronic acid' [patent_app_type] => utility [patent_app_number] => 12/733061 [patent_app_country] => US [patent_app_date] => 2008-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 32 [patent_no_of_words] => 13648 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12733061 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/733061
Nucleic acid delivery system comprising conjugates of PEI and hyaluronic acid Apr 3, 2008 Issued
Array ( [id] => 4534283 [patent_doc_number] => 07888326 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-15 [patent_title] => 'Methods for promoting apoptosis and treating tumor cells inhibiting the expression or function of the transcription factor ATF5' [patent_app_type] => utility [patent_app_number] => 12/062178 [patent_app_country] => US [patent_app_date] => 2008-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 27 [patent_no_of_words] => 34660 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/888/07888326.pdf [firstpage_image] =>[orig_patent_app_number] => 12062178 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/062178
Methods for promoting apoptosis and treating tumor cells inhibiting the expression or function of the transcription factor ATF5 Apr 2, 2008 Issued
Array ( [id] => 4563834 [patent_doc_number] => 07846725 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-07 [patent_title] => 'Antibody composition-producing cell in which enzyme expression is inhibited by RNAi' [patent_app_type] => utility [patent_app_number] => 12/060617 [patent_app_country] => US [patent_app_date] => 2008-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 73 [patent_no_of_words] => 77458 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/846/07846725.pdf [firstpage_image] =>[orig_patent_app_number] => 12060617 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/060617
Antibody composition-producing cell in which enzyme expression is inhibited by RNAi Mar 31, 2008 Issued
Array ( [id] => 4886393 [patent_doc_number] => 20080260725 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Tag and target delivery system' [patent_app_type] => utility [patent_app_number] => 12/079681 [patent_app_country] => US [patent_app_date] => 2008-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 7283 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20080260725.pdf [firstpage_image] =>[orig_patent_app_number] => 12079681 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/079681
Tag and target delivery system Mar 27, 2008 Abandoned
Array ( [id] => 7555331 [patent_doc_number] => 08067232 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => 'Antibody composition-producing cell with inactivated A-1,6-fusocyltransferase' [patent_app_type] => utility [patent_app_number] => 12/048343 [patent_app_country] => US [patent_app_date] => 2008-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 74 [patent_no_of_words] => 77436 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/067/08067232.pdf [firstpage_image] =>[orig_patent_app_number] => 12048343 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/048343
Antibody composition-producing cell with inactivated A-1,6-fusocyltransferase Mar 13, 2008 Issued
Array ( [id] => 4644589 [patent_doc_number] => 08022195 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-20 [patent_title] => 'Vectors encoding cell growth and adhesion factors for simultaneous growth and adhesion of cells' [patent_app_type] => utility [patent_app_number] => 12/075657 [patent_app_country] => US [patent_app_date] => 2008-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 13 [patent_no_of_words] => 15344 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/022/08022195.pdf [firstpage_image] =>[orig_patent_app_number] => 12075657 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/075657
Vectors encoding cell growth and adhesion factors for simultaneous growth and adhesion of cells Mar 12, 2008 Issued
Menu